Cargando…
Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression
To evaluate the age-related efficacy and safety of atropine 0.01% eye drops over 2 years for myopia control in a multicentric pediatric Spanish cohort. A non-controlled, interventional, prospective multicenter study was conducted as an extension of the Spanish Group of Atropine Treatment for Myopia...
Autores principales: | Pérez-Flores, Inés, Macías-Murelaga, Beatriz, Barrio-Barrio, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539365/ https://www.ncbi.nlm.nih.gov/pubmed/37770602 http://dx.doi.org/10.1038/s41598-023-43569-x |
Ejemplares similares
-
A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021) -
Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022) -
Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023) -
Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020) -
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)